Ningbo Menovo Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Y25
CNY
63.70
2.05 (3.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
337.65
439.46
400.85
276.48
423.78
341.20
345.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
337.65
439.46
400.85
276.48
423.78
341.20
345.11
Raw Material Cost
246.07
290.67
276.33
198.06
287.39
226.86
269.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.67
10.14
18.64
10.35
27.58
5.25
8.25
Selling and Distribution Expenses
41.14
55.93
58.21
34.25
58.97
49.74
47.83
Other Expenses
-0.11
1.40
0.41
0.23
0.51
1.43
1.58
Total Expenditure (Excl Depreciation)
296.80
370.79
357.26
244.93
379.01
296.18
341.84
Operating Profit (PBDIT) excl Other Income
40.9
68.7
43.6
31.6
44.800000000000004
45
3.3000000000000003
Other Income
6.97
4.84
12.91
10.71
18.93
17.81
-4.24
Operating Profit (PBDIT)
51.49
64.03
87.58
73.13
71.44
96.01
25.54
Interest
10.67
10.14
18.64
10.35
27.58
5.25
8.25
Exceptional Items
-3.68
3.39
-4.82
1.46
3.57
0.13
14.54
Gross Profit (PBDT)
91.58
148.79
124.52
78.43
136.39
114.34
75.15
Depreciation
0.00
0.00
35.36
35.36
38.96
38.96
29.41
Profit Before Tax
37.14
57.27
28.77
28.88
8.48
51.93
2.43
Tax
4.67
9.83
1.52
5.69
-3.87
8.23
1.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
31.16
46.87
27.83
21.22
3.56
44.31
4.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
31.16
46.87
27.83
21.22
3.56
44.31
4.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.31
1.18
2.06
1.97
4.78
2.17
0.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.47
48.05
29.90
23.19
8.34
46.48
5.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,377.24
2,314.74
2,245.80
2,219.26
2,192.74
2,171.10
2,115.87
Earnings per share (EPS)
0.13
0.2
0.1
0.1
0.02
0.21
0.01
Diluted Earnings per share
0.13
0.2
0.1
0.1
0.02
0.21
0.01
Operating Profit Margin (Excl OI)
13.18%
13.47%
9.81%
9.79%
3.2%
11.5%
0.11%
Gross Profit Margin
11.0%
13.03%
16.0%
23.24%
11.19%
26.64%
9.22%
PAT Margin
9.23%
10.67%
6.94%
7.68%
0.84%
12.99%
1.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -23.16% vs 9.66% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -32.43% vs 60.87% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -24.83% vs -20.75% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 5.94% vs -45.70% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

Compare Quarterly Results Of Ningbo Menovo Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
337.65
0
337.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
337.65
0
337.65
Raw Material Cost
246.07
0
246.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.67
0
10.67
Selling and Distribution Expenses
41.14
0
41.14
Other Expenses
-0.11
0.00
-0.11
Total Expenditure (Excl Depreciation)
296.80
0
296.80
Operating Profit (PBDIT) excl Other Income
40.85
0.00
40.85
Other Income
6.97
0
6.97
Operating Profit (PBDIT)
51.49
0
51.49
Interest
10.67
0
10.67
Exceptional Items
-3.68
0
-3.68
Gross Profit (PBDT)
91.58
0
91.58
Depreciation
0.00
0
0.00
Profit Before Tax
37.14
0
37.14
Tax
4.67
0
4.67
Provisions and contingencies
0
0
0.00
Profit After Tax
31.16
0
31.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
31.16
0
31.16
Share in Profit of Associates
0
0
0.00
Minority Interest
1.31
0
1.31
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.47
0
32.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,377.24
0
2,377.24
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
13.18%
0%
0.00
13.18%
Gross Profit Margin
11.00%
0%
0.00
11.00%
PAT Margin
9.23%
0%
0.00
9.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 33.77 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -23.16% vs 9.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 22.13% vs 5.21% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.25 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -32.43% vs 60.87% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 40.09% vs 46.84% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.45 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -24.83% vs -20.75% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -28.69% vs 13.45% in Mar 2025

Quarterly - Interest
Interest 1.07 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.94% vs -45.70% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.88% vs 44.44% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.18%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025